Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VDet al.(2025) Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial J Clin Oncol, JCO2401386(in press) DOI 10.1200/JCO-24-01386, PubMed 40249893
Helgesen FG, Tetteh MA, Johansen S(2025) A survey of diagnostic reference levels for head, chest, and abdomen and pelvis CT in private diagnostic facilities in Norway Acta Radiol, 2841851251330242(in press) DOI 10.1177/02841851251330242, PubMed 40232232
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Palme JÖ, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Traa T, Hagen RK, Frøland AS, Ramberg C, Kristiansen Cet al.(2025) Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study Lung Cancer, 203, 108527(in press) DOI 10.1016/j.lungcan.2025.108527, PubMed 40184836